positive
2 days agoAnthem Biosciences rises as Nomura issues positive coverage
Anthem Biosciences gained about 4% after Nomura assigned a Buy rating, noting that the stock trades nearly 14% above its IPO price. The brokerage highlighted a strong pipeline and favourable margin trends. Investor interest increased during the session as broader pharma sentiment improved.
Companies:
- Anthem Biosciences
Tags:
- anthem biosciences
- stocks
Explore:Mutual Fund Themes
positive
2 days agoAnthem Biosciences rises as Nomura issues positive coverage
Anthem Biosciences gained about 4% after Nomura assigned a Buy rating, noting that the stock trades nearly 14% above its IPO price. The brokerage highlighted a strong pipeline and favourable margin trends. Investor interest increased during the session as broader pharma sentiment improved.
Companies:
- Anthem Biosciences
Tags:
- anthem biosciences
- stocks
Explore:Mutual Fund Themes
Recently
1 min read
44 words
Anthem Biosciences rose 4% after Nomura gave a Buy rating, with the stock trading 14% above its IPO price.
Anthem Biosciences gained about 4% after Nomura assigned a Buy rating, noting that the stock trades nearly 14% above its IPO price. The brokerage highlighted a strong pipeline and favourable margin trends. Investor interest increased during the session as broader pharma sentiment improved.
Anthem Biosciences gained about 4% after Nomura assigned a Buy rating, noting that the stock trades nearly 14% above its IPO price. The brokerage highlighted a strong pipeline and favourable margin trends. Investor interest increased during the session as broader pharma sentiment improved.
Companies:
- Anthem Biosciences
Tags:
- anthem biosciences
- stocks
- anthem biosciences
- stocks
- nomura
Nov 29, 2025 • 16:11